Search Results for: SRC

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
NCOA6 nuclear receptor coactivator 6
  • RORA activates gene expression
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • PPARA activates gene expression
  • PPARA activates gene expression
  • Transcriptional activation of mitochondrial biogenesis
  • Activation of gene expression by SREBF (SREBP)
  • Transcriptional regulation of white adipocyte differentiation
  • Regulation of lipid metabolism by PPARalpha
  • Circadian Clock
  • Activation of anterior HOX genes in hindbrain development during early embryogenesis
NEDD4 NEDD4 E3 ubiquitin protein ligase
  • ISG15 antiviral mechanism
  • Downregulation of ERBB4 signaling
  • Regulation of PTEN localization
  • Regulation of PTEN stability and activity
  • Antigen processing: Ubiquitination & Proteasome degradation
NFKBIA NFKB inhibitor alpha
  • Activation of NF-kappaB in B cells
  • RIP-mediated NFkB activation via ZBP1
  • Downstream TCR signaling
  • NF-kB is activated and signals survival
  • FCERI mediated NF-kB activation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • SUMOylation of immune response proteins
  • IkBA variant leads to EDA-ID
  • CLEC7A (Dectin-1) signaling
  • Ub-specific processing proteases
  • Interleukin-1 signaling
  • TRAF6 mediated NF-kB activation
  • Acetylsalicylic acid
  • Bardoxolone methyl
  • Astaxanthin
  • Ectodermal dysplasia associated immunodeficiency (EDA-ID), including the following two diseases: NF-kappa-B essential modulator (NEMO) defect; Inhibitor of kappa-B (I-kappa-B) defect
  • Hodgkin lymphoma
NMT1 N-myristoyltransferase 1
  • Late Phase of HIV Life Cycle
  • Inactivation, recovery and regulation of the phototransduction cascade
  • Activation, myristolyation of BID and translocation to mitochondria
  • (1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone
NOS2 nitric oxide synthase 2
  • ROS and RNS production in phagocytes
  • Nitric oxide stimulates guanylate cyclase
  • Interleukin-4 and Interleukin-13 signaling
  • Peroxisomal protein import
  • Peroxisomal protein import
  • Inhibition of nitric oxide production
  • Arginine
  • Citrulline
  • Minocycline
  • Miconazole
  • Dexamethasone
  • N,N-dimethylarginine
  • 4R-Fluoro-N6-ethanimidoyl-L-lysine
  • 3-Bromo-7-Nitroindazole
  • N-[3-(aminomethyl)benzyl]acetamidine
  • 7-Nitroindazole
  • S-Ethylisothiourea
  • Thiocoumarin
  • N-omega-propyl-L-arginine
  • 6-Nitroindazole
  • N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine
  • Imidazole
  • N-(4-{2-[(3-chlorobenzyl)amino]ethyl}phenyl)thiophene-2-carboximidamide
  • Thiocitrulline
  • L-erythro-7,8-dihydrobiopterin
  • 5-Nitroindazole
  • KD7040
  • Fenoxaprop-ethyl
  • Pimagedine
  • 5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE
  • N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE
  • 4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile
  • (2S)-2-methyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine
  • (3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine
  • 4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE
  • (3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE
  • 4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE
  • ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE
  • N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE
  • ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE
  • N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE
  • 1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE
  • 4-(1H-IMIDAZOL-1-YL)PHENOL
  • 1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE
  • Triflusal
  • Levamlodipine
  • Dipyrithione
  • Dexamethasone acetate
  • Esophageal cancer
NPHS1 NPHS1 adhesion molecule, nephrin
  • Nephrin family interactions
  • Nephrin family interactions
  • Nephrotic syndrome and focal segmental glomerulosclerosis
NR1I2 nuclear receptor subfamily 1 group I member 2
  • Vitamin E
  • Oxiconazole
  • Phenytoin
  • Diethylstilbestrol
  • Clotrimazole
  • Pentobarbital
  • Spironolactone
  • Lindane
  • Flutamide
  • Ritonavir
  • Erlotinib
  • Cyclophosphamide
  • Mephenytoin
  • Carbamazepine
  • Tamoxifen
  • Warfarin
  • Ethotoin
  • Estradiol
  • Mifepristone
  • Methylphenobarbital
  • Ethinylestradiol
  • Ketoconazole
  • Fenofibrate
  • Rifampicin
  • Clonazepam
  • Miconazole
  • Nifedipine
  • Econazole
  • Sulfinpyrazone
  • Phenobarbital
  • Ifosfamide
  • Rifaximin
  • Paclitaxel
  • Dexamethasone
  • Docetaxel
  • Bezafibrate
  • Genistein
  • Prasterone
  • Hyperforin
  • Resveratrol
  • Pregnenolone
  • Quercetin
  • SR12813
  • Afimoxifene
  • Phenolphthalein
  • Permethrin
  • Dovitinib
  • Chenodeoxycholic acid
  • TO-901317
  • Hexestrol
  • Triclosan
  • Rilpivirine
  • Pyrethrum extract
  • Myrrh
  • Piperine
  • Troleandomycin
  • Fenofibric acid
  • Estradiol acetate
  • Estradiol benzoate
  • Estradiol cypionate
  • Estradiol dienanthate
  • Estradiol valerate
  • alpha-Tocopherol succinate
  • D-alpha-Tocopherol acetate
  • Dexamethasone acetate
NR1I3 nuclear receptor subfamily 1 group I member 3
  • Doxylamine
  • Meclizine
  • Loperamide
  • Ketoconazole
  • Atorvastatin
  • Pheniramine
  • Prasterone
  • 16,17-Androstene-3-Ol
  • Resveratrol
  • Cholesterol
  • Phenolphthalein
  • 3,20-Pregnanedione
  • Hexestrol
  • Triclosan
NR3C1 nuclear receptor subfamily 3 group C member 1
  • HSP90 chaperone cycle for steroid hormone receptors (SHR)
  • Circadian Clock
  • SUMOylation of intracellular receptors
  • PTK6 Expression
  • Regulation of RUNX2 expression and activity
  • FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
  • Potential therapeutics for SARS
  • Flunisolide
  • Diflorasone
  • Alclometasone
  • Medrysone
  • Amcinonide
  • Fluorometholone
  • Megestrol acetate
  • Levonorgestrel
  • Beclomethasone dipropionate
  • Progesterone
  • Spironolactone
  • Betamethasone
  • Desoximetasone
  • Fluticasone propionate
  • Fluocinolone acetonide
  • Ulobetasol
  • Triamcinolone
  • Prednisone
  • Flumethasone
  • Fludrocortisone
  • Norethisterone
  • Hydrocortisone
  • Mometasone
  • Hydrocortamate
  • Mifepristone
  • Clocortolone
  • Flurandrenolide
  • Prednisolone
  • Loteprednol etabonate
  • Rimexolone
  • Methylprednisolone
  • Clobetasol propionate
  • Fluocinonide
  • Prednicarbate
  • Fluoxymesterone
  • Budesonide
  • Dexamethasone
  • Desonide
  • Cortisone acetate
  • Paramethasone
  • Drospirenone
  • Ciclesonide
  • Hexane-1,6-Diol
  • Aldosterone
  • ORG-34517
  • Difluprednate
  • Ulipristal
  • Fluticasone furoate
  • Tixocortol
  • Difluocortolone
  • Gestrinone
  • Deflazacort
  • Onapristone
  • Cortivazol
  • Clobetasone
  • Fluticasone
  • Mometasone furoate
  • Hydrocortisone aceponate
  • Hydrocortisone acetate
  • Hydrocortisone butyrate
  • Hydrocortisone cypionate
  • Hydrocortisone phosphate
  • Hydrocortisone probutate
  • Hydrocortisone valerate
  • Segesterone acetate
  • Prednisolone phosphate
  • Dexamethasone acetate
  • Betamethasone phosphate
  • Prednisolone acetate
  • 46,XX disorders of sex development (Disorders related to androgen excess), including: Congenital adrenal hyperplasias; Glucocorticoid resistance; Aromatase deficiency
P2RY2 purinergic receptor P2Y2
  • G alpha (q) signalling events
  • P2Y receptors
  • Surfactant metabolism
  • Promethazine
  • Suramin
  • Denufosol
  • INS 316
PAK2 p21 (RAC1) activated kinase 2
  • Nef and signal transduction
  • Generation of second messenger molecules
  • Regulation of PAK-2p34 activity by PS-GAP/RHG10
  • Regulation of activated PAK-2p34 by proteasome mediated degradation
  • Stimulation of the cell death response by PAK-2p34
  • FCERI mediated MAPK activation
  • FCERI mediated MAPK activation
  • CD28 dependent Vav1 pathway
  • Ephrin signaling
  • Sema3A PAK dependent Axon repulsion
  • Activation of RAC1
  • VEGFA-VEGFR2 Pathway
  • Smooth Muscle Contraction
  • VEGFR2 mediated vascular permeability
  • CD209 (DC-SIGN) signaling
  • RHO GTPases activate PAKs
  • RHO GTPases activate PAKs
  • MAPK6/MAPK4 signaling
  • Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
  • Fostamatinib
PDCD6IP programmed cell death 6 interacting protein
  • Budding and maturation of HIV virion
  • Uptake and function of anthrax toxins
  • RIPK1-mediated regulated necrosis
  • Regulation of necroptotic cell death
PDE4D phosphodiesterase 4D
  • DARPP-32 events
  • G alpha (s) signalling events
  • Adenosine phosphate
  • Caffeine
  • Caffeine
  • Dyphylline
  • Iloprost
  • Amrinone
  • Roflumilast
  • Piclamilast
  • Rolipram
  • 3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
  • 2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol
  • Zardaverine
  • 1-(4-Aminophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
  • (S)-Rolipram
  • Cilomilast
  • (R)-Rolipram
  • 3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
  • 1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
  • Crisaborole
  • Ibudilast
  • Tetomilast
  • Exisulind
  • (4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one
  • 3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
  • 3-isobutyl-1-methyl-7H-xanthine
  • 4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid
  • Trapidil
PDE6G phosphodiesterase 6G
  • Activation of the phototransduction cascade
  • Activation of the phototransduction cascade
  • Inactivation, recovery and regulation of the phototransduction cascade
  • Ca2+ pathway
  • Ca2+ pathway
  • Sildenafil
  • Vardenafil
  • 3-isobutyl-1-methyl-7H-xanthine
  • Retinitis pigmentosa (RP)
PDGFRB platelet derived growth factor receptor beta
  • PIP3 activates AKT signaling
  • Downstream signal transduction
  • Signaling by PDGF
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • RAF/MAP kinase cascade
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • Becaplermin
  • Sorafenib
  • Imatinib
  • Dasatinib
  • Sunitinib
  • XL999
  • XL820
  • Pazopanib
  • Midostaurin
  • Regorafenib
  • Nintedanib
  • Polaprezinc
  • Trapidil
  • Foreskin fibroblast (neonatal)
  • Fostamatinib
  • Erdafitinib
  • Pexidartinib
  • Ripretinib
  • Pralsetinib
  • Glioma
PDPK1 3-phosphoinositide dependent protein kinase 1
  • GPVI-mediated activation cascade
  • GPVI-mediated activation cascade
  • PIP3 activates AKT signaling
  • Activation of AKT2
  • Downstream TCR signaling
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • FCERI mediated NF-kB activation
  • Integrin signaling
  • CD28 dependent PI3K/Akt signaling
  • G beta:gamma signalling through PI3Kgamma
  • RSK activation
  • VEGFR2 mediated vascular permeability
  • VEGFR2 mediated cell proliferation
  • CLEC7A (Dectin-1) signaling
  • RHO GTPases activate PKNs
  • Constitutive Signaling by AKT1 E17K in Cancer
  • Regulation of TP53 Degradation
  • Estrogen-stimulated signaling through PRKCZ
  • Estrogen-stimulated signaling through PRKCZ
  • Celecoxib
  • Inositol 1,3,4,5-Tetrakisphosphate
  • 7-Hydroxystaurosporine
  • Bisindolylmaleimide VIII
  • Staurosporine
  • Bisindolylmaleimide I
  • Dexfosfoserine
  • 10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine
  • 5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE
  • 1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA
  • 2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine
  • 3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione
  • 3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE
  • Fostamatinib
PECAM1 platelet and endothelial cell adhesion molecule 1
  • Platelet degranulation
  • Cell surface interactions at the vascular wall
  • PECAM1 interactions
  • Integrin cell surface interactions
  • Platelet sensitization by LDL
  • Neutrophil degranulation
PELP1 proline, glutamate and leucine rich protein 1
  • Major pathway of rRNA processing in the nucleolus and cytosol
  • PTK6 Expression
PGR progesterone receptor
  • Nuclear signaling by ERBB4
  • HSP90 chaperone cycle for steroid hormone receptors (SHR)
  • Nuclear Receptor transcription pathway
  • SUMOylation of intracellular receptors
  • Estrogen-dependent gene expression
  • Etonogestrel
  • Desogestrel
  • Megestrol acetate
  • Levonorgestrel
  • Dydrogesterone
  • Progesterone
  • Spironolactone
  • Lindane
  • Fluticasone propionate
  • Medroxyprogesterone acetate
  • Mitotane
  • Norethisterone
  • Mometasone
  • Ethynodiol diacetate
  • Mifepristone
  • Norgestimate
  • Drospirenone
  • Danazol
  • Oxybenzone
  • Allylestrenol
  • Phthalic Acid
  • Metribolone
  • Tanaproget
  • Telapristone acetate
  • Asoprisnil
  • Norelgestromin
  • Gestodene
  • Hydroxyprogesterone caproate
  • Ulipristal
  • Fluticasone furoate
  • Dienogest
  • Medrogestone
  • Norgestrel
  • Homosalate
  • Enzacamene
  • Gestrinone
  • Darolutamide
  • Demegestone
  • Fluticasone
  • Mometasone furoate
  • Segesterone acetate
PIK3R1 phosphoinositide-3-kinase regulatory subunit 1
  • PI3K Cascade
  • IRS-mediated signalling
  • GPVI-mediated activation cascade
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • PI3K events in ERBB4 signaling
  • PIP3 activates AKT signaling
  • Interleukin-7 signaling
  • Interleukin-7 signaling
  • Signaling by SCF-KIT
  • Synthesis of PIPs at the plasma membrane
  • GAB1 signalosome
  • Signaling by cytosolic FGFR1 fusion mutants
  • Downstream signal transduction
  • PI3K events in ERBB2 signaling
  • PI3K/AKT activation
  • Downstream TCR signaling
  • Role of phospholipids in phagocytosis
  • Tie2 Signaling
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • DAP12 signaling
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Nephrin family interactions
  • Costimulation by the CD28 family
  • CD28 dependent PI3K/Akt signaling
  • G alpha (q) signalling events
  • GP1b-IX-V activation signalling
  • VEGFA-VEGFR2 Pathway
  • VEGFA-VEGFR2 Pathway
  • Interleukin-3, Interleukin-5 and GM-CSF signaling
  • Constitutive Signaling by EGFRvIII
  • PI-3K cascade:FGFR1
  • PI-3K cascade:FGFR2
  • PI-3K cascade:FGFR3
  • PI-3K cascade:FGFR4
  • Signaling by FGFR2 in disease
  • Signaling by FGFR4 in disease
  • Signaling by FGFR1 in disease
  • RAF/MAP kinase cascade
  • Interleukin-4 and Interleukin-13 signaling
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • MET activates PI3K/AKT signaling
  • Signaling by FGFR3 fusions in cancer
  • Signaling by FGFR3 point mutants in cancer
  • RET signaling
  • Extra-nuclear estrogen signaling
  • Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
  • Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
  • Activated NTRK2 signals through PI3K
  • Interleukin receptor SHC signaling
  • Regulation of signaling by CBL
  • Regulation of signaling by CBL
  • Activated NTRK3 signals through PI3K
  • FLT3 Signaling
  • FLT3 Signaling
  • Signaling by ERBB2 KD Mutants
  • Signaling by ERBB2 ECD mutants
  • Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants
  • Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants
  • Signaling by PDGFRA extracellular domain mutants
  • Signaling by FLT3 fusion proteins
  • Signaling by FLT3 fusion proteins
  • Signaling by FLT3 ITD and TKD mutants
  • Signaling by FLT3 ITD and TKD mutants
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Isoprenaline
  • SF1126
  • Enzastaurin
  • Wortmannin

Page 10 out of 16 pages